Global and China PCR-based Enteric Disease Testing Market Size, Status and Forecast 2020-2026

August 2020 | 156 pages | ID: G98D5CA60344EN
QYResearch

Abstracts

Global PCR-based Enteric Disease Testing Scope and Market Size
PCR-based Enteric Disease Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global PCR-based Enteric Disease Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into

• Analyzers/Instruments
• Kits/Panels

Market segment by Application, split into

• Clostridium Difficile
• Campylobacteriosis
• Cholera
• E. coli Infection
• H. pylori Infection
• Salmonellosis
• Shigellosis
• Rotavirus Infection
• Norovirus Infection

Based on regional and country-level analysis, the PCR-based Enteric Disease Testing market has been segmented as follows:

• North America
• United States
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia-Pacific
• Latin America
• Mexico
• Brazil
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global PCR-based Enteric Disease Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study

• Thermo Fisher Scientific
• Vela Diagnostics
• CorisBioconcept
• Meridian Life Science
• Bio-Rad Laboratories
• Abbott (ALERE)
• bioMerieux SA
• Trinity Biotech
• DiaSorin Molecular
• Etta Healthcare (Ovagene Oncology)
• ExcitePCR (PositiveID Corporation)
• Flow Alliance
• Fluid-Screen
• FluimediX
• Fluxergy
• Focus Diagnostics (DiaSorin Molecular)
• Future Horizon Scientific
• Genalyte
• GeneFluidics
• GenSpeed Biotech
• Gulf Bio Analytical
• Hahn-Schickard
• Helvoet
• HemoCue
• Danaher
• IDEX Health&Science
• iLine Microsystems
• Inflammatix

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global PCR-based Enteric Disease Testing Market Size Growth Rate by Type: 2020 VS 2026
  1.2.2 Analyzers/Instruments
  1.2.3 Kits/Panels
1.3 Market by Application
  1.3.1 Global PCR-based Enteric Disease Testing Market Share by Application: 2020 VS 2026
  1.3.2 Clostridium Difficile
  1.3.3 Campylobacteriosis
  1.3.4 Cholera
  1.3.5 E. coli Infection
  1.3.6 H. pylori Infection
  1.3.7 Salmonellosis
  1.3.8 Shigellosis
  1.3.9 Rotavirus Infection
  1.3.10 Norovirus Infection
  1.3.11 Parasitic Enteric Disease
1.4 Study Objectives
1.5 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global PCR-based Enteric Disease Testing Market Perspective (2015-2026)
2.2 Global PCR-based Enteric Disease Testing Growth Trends by Regions
  2.2.1 PCR-based Enteric Disease Testing Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 PCR-based Enteric Disease Testing Historic Market Share by Regions (2015-2020)
  2.2.3 PCR-based Enteric Disease Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top PCR-based Enteric Disease Testing Players by Market Size
  3.1.1 Global Top PCR-based Enteric Disease Testing Players by Revenue (2015-2020)
  3.1.2 Global PCR-based Enteric Disease Testing Revenue Market Share by Players (2015-2020)
3.2 Global PCR-based Enteric Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by PCR-based Enteric Disease Testing Revenue
3.4 Global PCR-based Enteric Disease Testing Market Concentration Ratio
  3.4.1 Global PCR-based Enteric Disease Testing Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by PCR-based Enteric Disease Testing Revenue in 2019
3.5 Key Players PCR-based Enteric Disease Testing Area Served
3.6 Key Players PCR-based Enteric Disease Testing Product Solution and Service
3.7 Date of Enter into PCR-based Enteric Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 PCR-BASED ENTERIC DISEASE TESTING BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global PCR-based Enteric Disease Testing Historic Market Size by Type (2015-2020)
4.2 Global PCR-based Enteric Disease Testing Forecasted Market Size by Type (2021-2026)

5 PCR-BASED ENTERIC DISEASE TESTING BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global PCR-based Enteric Disease Testing Historic Market Size by Application (2015-2020)
5.2 Global PCR-based Enteric Disease Testing Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America PCR-based Enteric Disease Testing Market Size (2015-2026)
6.2 North America PCR-based Enteric Disease Testing Market Size by Type (2015-2020)
6.3 North America PCR-based Enteric Disease Testing Market Size by Application (2015-2020)
6.4 North America PCR-based Enteric Disease Testing Market Size by Country (2015-2020)
  6.4.1 United States
  6.4.2 Canada

7 EUROPE

7.1 Europe PCR-based Enteric Disease Testing Market Size (2015-2026)
7.2 Europe PCR-based Enteric Disease Testing Market Size by Type (2015-2020)
7.3 Europe PCR-based Enteric Disease Testing Market Size by Application (2015-2020)
7.4 Europe PCR-based Enteric Disease Testing Market Size by Country (2015-2020)
  7.4.1 Germany
  7.4.2 France
  7.4.3 U.K.
  7.4.4 Italy
  7.4.5 Russia
  7.4.6 Nordic
  7.4.7 Rest of Europe

8 CHINA

8.1 China PCR-based Enteric Disease Testing Market Size (2015-2026)
8.2 China PCR-based Enteric Disease Testing Market Size by Type (2015-2020)
8.3 China PCR-based Enteric Disease Testing Market Size by Application (2015-2020)
8.4 China PCR-based Enteric Disease Testing Market Size by Region (2015-2020)
  8.4.1 China
  8.4.2 Japan
  8.4.3 South Korea
  8.4.4 Southeast Asia
  8.4.5 India
  8.4.6 Australia
  8.4.7 Rest of Asia-Pacific

9 JAPAN

9.1 Japan PCR-based Enteric Disease Testing Market Size (2015-2026)
9.2 Japan PCR-based Enteric Disease Testing Market Size by Type (2015-2020)
9.3 Japan PCR-based Enteric Disease Testing Market Size by Application (2015-2020)
9.4 Japan PCR-based Enteric Disease Testing Market Size by Country (2015-2020)
  9.4.1 Mexico
  9.4.2 Brazil

10 SOUTHEAST ASIA

10.1 Southeast Asia PCR-based Enteric Disease Testing Market Size (2015-2026)
10.2 Southeast Asia PCR-based Enteric Disease Testing Market Size by Type (2015-2020)
10.3 Southeast Asia PCR-based Enteric Disease Testing Market Size by Application (2015-2020)
10.4 Southeast Asia PCR-based Enteric Disease Testing Market Size by Country (2015-2020)
  10.4.1 Turkey
  10.4.2 Saudi Arabia
  10.4.3 UAE
  10.4.4 Rest of Middle East & Africa

11KEY PLAYERS PROFILES

11.1 Thermo Fisher Scientific
  11.1.1 Thermo Fisher Scientific Company Details
  11.1.2 Thermo Fisher Scientific Business Overview
  11.1.3 Thermo Fisher Scientific PCR-based Enteric Disease Testing Introduction
  11.1.4 Thermo Fisher Scientific Revenue in PCR-based Enteric Disease Testing Business (2015-2020))
  11.1.5 Thermo Fisher Scientific Recent Development
11.2 Vela Diagnostics
  11.2.1 Vela Diagnostics Company Details
  11.2.2 Vela Diagnostics Business Overview
  11.2.3 Vela Diagnostics PCR-based Enteric Disease Testing Introduction
  11.2.4 Vela Diagnostics Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  11.2.5 Vela Diagnostics Recent Development
11.3 CorisBioconcept
  11.3.1 CorisBioconcept Company Details
  11.3.2 CorisBioconcept Business Overview
  11.3.3 CorisBioconcept PCR-based Enteric Disease Testing Introduction
  11.3.4 CorisBioconcept Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  11.3.5 CorisBioconcept Recent Development
11.4 Meridian Life Science
  11.4.1 Meridian Life Science Company Details
  11.4.2 Meridian Life Science Business Overview
  11.4.3 Meridian Life Science PCR-based Enteric Disease Testing Introduction
  11.4.4 Meridian Life Science Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  11.4.5 Meridian Life Science Recent Development
11.5 Bio-Rad Laboratories
  11.5.1 Bio-Rad Laboratories Company Details
  11.5.2 Bio-Rad Laboratories Business Overview
  11.5.3 Bio-Rad Laboratories PCR-based Enteric Disease Testing Introduction
  11.5.4 Bio-Rad Laboratories Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  11.5.5 Bio-Rad Laboratories Recent Development
11.6 Abbott (ALERE)
  11.6.1 Abbott (ALERE) Company Details
  11.6.2 Abbott (ALERE) Business Overview
  11.6.3 Abbott (ALERE) PCR-based Enteric Disease Testing Introduction
  11.6.4 Abbott (ALERE) Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  11.6.5 Abbott (ALERE) Recent Development
11.7 bioMerieux SA
  11.7.1 bioMerieux SA Company Details
  11.7.2 bioMerieux SA Business Overview
  11.7.3 bioMerieux SA PCR-based Enteric Disease Testing Introduction
  11.7.4 bioMerieux SA Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  11.7.5 bioMerieux SA Recent Development
11.8 Trinity Biotech
  11.8.1 Trinity Biotech Company Details
  11.8.2 Trinity Biotech Business Overview
  11.8.3 Trinity Biotech PCR-based Enteric Disease Testing Introduction
  11.8.4 Trinity Biotech Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  11.8.5 Trinity Biotech Recent Development
11.9 DiaSorin Molecular
  11.9.1 DiaSorin Molecular Company Details
  11.9.2 DiaSorin Molecular Business Overview
  11.9.3 DiaSorin Molecular PCR-based Enteric Disease Testing Introduction
  11.9.4 DiaSorin Molecular Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  11.9.5 DiaSorin Molecular Recent Development
11.10 Etta Healthcare (Ovagene Oncology)
  11.10.1 Etta Healthcare (Ovagene Oncology) Company Details
  11.10.2 Etta Healthcare (Ovagene Oncology) Business Overview
  11.10.3 Etta Healthcare (Ovagene Oncology) PCR-based Enteric Disease Testing Introduction
  11.10.4 Etta Healthcare (Ovagene Oncology) Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  11.10.5 Etta Healthcare (Ovagene Oncology) Recent Development
11.11 ExcitePCR (PositiveID Corporation)
  10.11.1 ExcitePCR (PositiveID Corporation) Company Details
  10.11.2 ExcitePCR (PositiveID Corporation) Business Overview
  10.11.3 ExcitePCR (PositiveID Corporation) PCR-based Enteric Disease Testing Introduction
  10.11.4 ExcitePCR (PositiveID Corporation) Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  10.11.5 ExcitePCR (PositiveID Corporation) Recent Development
11.12 Flow Alliance
  10.12.1 Flow Alliance Company Details
  10.12.2 Flow Alliance Business Overview
  10.12.3 Flow Alliance PCR-based Enteric Disease Testing Introduction
  10.12.4 Flow Alliance Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  10.12.5 Flow Alliance Recent Development
11.13 Fluid-Screen
  10.13.1 Fluid-Screen Company Details
  10.13.2 Fluid-Screen Business Overview
  10.13.3 Fluid-Screen PCR-based Enteric Disease Testing Introduction
  10.13.4 Fluid-Screen Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  10.13.5 Fluid-Screen Recent Development
11.14 FluimediX
  10.14.1 FluimediX Company Details
  10.14.2 FluimediX Business Overview
  10.14.3 FluimediX PCR-based Enteric Disease Testing Introduction
  10.14.4 FluimediX Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  10.14.5 FluimediX Recent Development
11.15 Fluxergy
  10.15.1 Fluxergy Company Details
  10.15.2 Fluxergy Business Overview
  10.15.3 Fluxergy PCR-based Enteric Disease Testing Introduction
  10.15.4 Fluxergy Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  10.15.5 Fluxergy Recent Development
11.16 Focus Diagnostics (DiaSorin Molecular)
  10.16.1 Focus Diagnostics (DiaSorin Molecular) Company Details
  10.16.2 Focus Diagnostics (DiaSorin Molecular) Business Overview
  10.16.3 Focus Diagnostics (DiaSorin Molecular) PCR-based Enteric Disease Testing Introduction
  10.16.4 Focus Diagnostics (DiaSorin Molecular) Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  10.16.5 Focus Diagnostics (DiaSorin Molecular) Recent Development
11.17 Future Horizon Scientific
  10.17.1 Future Horizon Scientific Company Details
  10.17.2 Future Horizon Scientific Business Overview
  10.17.3 Future Horizon Scientific PCR-based Enteric Disease Testing Introduction
  10.17.4 Future Horizon Scientific Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  10.17.5 Future Horizon Scientific Recent Development
11.18 Genalyte
  10.18.1 Genalyte Company Details
  10.18.2 Genalyte Business Overview
  10.18.3 Genalyte PCR-based Enteric Disease Testing Introduction
  10.18.4 Genalyte Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  10.18.5 Genalyte Recent Development
11.19 GeneFluidics
  10.19.1 GeneFluidics Company Details
  10.19.2 GeneFluidics Business Overview
  10.19.3 GeneFluidics PCR-based Enteric Disease Testing Introduction
  10.19.4 GeneFluidics Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  10.19.5 GeneFluidics Recent Development
11.20 GenSpeed Biotech
  10.20.1 GenSpeed Biotech Company Details
  10.20.2 GenSpeed Biotech Business Overview
  10.20.3 GenSpeed Biotech PCR-based Enteric Disease Testing Introduction
  10.20.4 GenSpeed Biotech Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  10.20.5 GenSpeed Biotech Recent Development
11.21 Gulf Bio Analytical
  10.21.1 Gulf Bio Analytical Company Details
  10.21.2 Gulf Bio Analytical Business Overview
  10.21.3 Gulf Bio Analytical PCR-based Enteric Disease Testing Introduction
  10.21.4 Gulf Bio Analytical Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  10.21.5 Gulf Bio Analytical Recent Development
11.22 Hahn-Schickard
  10.22.1 Hahn-Schickard Company Details
  10.22.2 Hahn-Schickard Business Overview
  10.22.3 Hahn-Schickard PCR-based Enteric Disease Testing Introduction
  10.22.4 Hahn-Schickard Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  10.22.5 Hahn-Schickard Recent Development
11.23 Helvoet
  10.23.1 Helvoet Company Details
  10.23.2 Helvoet Business Overview
  10.23.3 Helvoet PCR-based Enteric Disease Testing Introduction
  10.23.4 Helvoet Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  10.23.5 Helvoet Recent Development
11.24 HemoCue
  10.24.1 HemoCue Company Details
  10.24.2 HemoCue Business Overview
  10.24.3 HemoCue PCR-based Enteric Disease Testing Introduction
  10.24.4 HemoCue Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  10.24.5 HemoCue Recent Development
11.25 Danaher
  10.25.1 Danaher Company Details
  10.25.2 Danaher Business Overview
  10.25.3 Danaher PCR-based Enteric Disease Testing Introduction
  10.25.4 Danaher Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  10.25.5 Danaher Recent Development
11.26 IDEX Health&Science
  10.26.1 IDEX Health&Science Company Details
  10.26.2 IDEX Health&Science Business Overview
  10.26.3 IDEX Health&Science PCR-based Enteric Disease Testing Introduction
  10.26.4 IDEX Health&Science Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  10.26.5 IDEX Health&Science Recent Development
11.27 iLine Microsystems
  10.27.1 iLine Microsystems Company Details
  10.27.2 iLine Microsystems Business Overview
  10.27.3 iLine Microsystems PCR-based Enteric Disease Testing Introduction
  10.27.4 iLine Microsystems Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  10.27.5 iLine Microsystems Recent Development
11.28 Inflammatix
  10.28.1 Inflammatix Company Details
  10.28.2 Inflammatix Business Overview
  10.28.3 Inflammatix PCR-based Enteric Disease Testing Introduction
  10.28.4 Inflammatix Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
  10.28.5 Inflammatix Recent Development

12ANALYST'S VIEWPOINTS/CONCLUSIONS

13APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Global PCR-based Enteric Disease Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Analyzers/Instruments
Table 4. Key Players of Kits/Panels
Table 5. Global PCR-based Enteric Disease Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global PCR-based Enteric Disease Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global PCR-based Enteric Disease Testing Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global PCR-based Enteric Disease Testing Market Share by Regions (2015-2020)
Table 9. Global PCR-based Enteric Disease Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global PCR-based Enteric Disease Testing Market Share by Regions (2021-2026)
Table 11. PCR-based Enteric Disease Testing Market Market Trends
Table 12. PCR-based Enteric Disease Testing Market Drivers
Table 13. PCR-based Enteric Disease Testing Market Challenges
Table 14. PCR-based Enteric Disease Testing Market Restraints
Table 15. Global PCR-based Enteric Disease Testing Revenue by Players (2015-2020) (US$ Million)
Table 16. Global PCR-based Enteric Disease Testing Market Share by Players (2015-2020)
Table 17. Global Top PCR-based Enteric Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PCR-based Enteric Disease Testing as of 2019)
Table 18. Global PCR-based Enteric Disease Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players PCR-based Enteric Disease Testing Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global PCR-based Enteric Disease Testing Market Size by Type (2015-2020) (US$ Million)
Table 23. Global PCR-based Enteric Disease Testing Market Size Share by Type (2015-2020)
Table 24. Global PCR-based Enteric Disease Testing Revenue Market Share by Type (2021-2026)
Table 25. Global PCR-based Enteric Disease Testing Market Size Share by Application (2015-2020)
Table 26. Global PCR-based Enteric Disease Testing Market Size by Application (2015-2020) (US$ Million)
Table 27. Global PCR-based Enteric Disease Testing Market Size Share by Application (2021-2026)
Table 28. North America PCR-based Enteric Disease Testing Market Size by Type (2015-2020) (US$ Million)
Table 29. North America PCR-based Enteric Disease Testing Market Share by Type (2015-2020)
Table 30. North America PCR-based Enteric Disease Testing Market Size by Application (2015-2020) (US$ Million)
Table 31. North America PCR-based Enteric Disease Testing Market Share by Application (2015-2020)
Table 32. North America PCR-based Enteric Disease Testing Market Size by Country (US$ Million) (2015-2020)
Table 33. North America PCR-based Enteric Disease Testing Market Share by Country (2015-2020)
Table 34. Europe PCR-based Enteric Disease Testing Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe PCR-based Enteric Disease Testing Market Share by Type (2015-2020)
Table 36. Europe PCR-based Enteric Disease Testing Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe PCR-based Enteric Disease Testing Market Share by Application (2015-2020)
Table 38. Europe PCR-based Enteric Disease Testing Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe PCR-based Enteric Disease Testing Market Share by Country (2015-2020)
Table 40. China PCR-based Enteric Disease Testing Market Size by Type (2015-2020) (US$ Million)
Table 41. China PCR-based Enteric Disease Testing Market Share by Type (2015-2020)
Table 42. China PCR-based Enteric Disease Testing Market Size by Application (2015-2020) (US$ Million)
Table 43. China PCR-based Enteric Disease Testing Market Share by Application (2015-2020)
Table 44. China PCR-based Enteric Disease Testing Market Size by Region (US$ Million) (2015-2020)
Table 45. China PCR-based Enteric Disease Testing Market Share by Region (2015-2020)
Table 46. Japan PCR-based Enteric Disease Testing Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan PCR-based Enteric Disease Testing Market Share by Type (2015-2020)
Table 48. Japan PCR-based Enteric Disease Testing Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan PCR-based Enteric Disease Testing Market Share by Application (2015-2020)
Table 50. Japan PCR-based Enteric Disease Testing Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan PCR-based Enteric Disease Testing Market Share by Country (2015-2020)
Table 52. Southeast Asia PCR-based Enteric Disease Testing Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia PCR-based Enteric Disease Testing Market Share by Type (2015-2020)
Table 54. Southeast Asia PCR-based Enteric Disease Testing Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia PCR-based Enteric Disease Testing Market Share by Application (2015-2020)
Table 56. Southeast Asia PCR-based Enteric Disease Testing Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia PCR-based Enteric Disease Testing Market Share by Country (2015-2020)
Table 58. Thermo Fisher Scientific Company Details
Table 59. Thermo Fisher Scientific Business Overview
Table 60. Thermo Fisher Scientific Product
Table 61. Thermo Fisher Scientific Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 62. Thermo Fisher Scientific Recent Development
Table 63. Vela Diagnostics Company Details
Table 64. Vela Diagnostics Business Overview
Table 65. Vela Diagnostics Product
Table 66. Vela Diagnostics Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 67. Vela Diagnostics Recent Development
Table 68. CorisBioconcept Company Details
Table 69. CorisBioconcept Business Overview
Table 70. CorisBioconcept Product
Table 71. CorisBioconcept Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 72. CorisBioconcept Recent Development
Table 73. Meridian Life Science Company Details
Table 74. Meridian Life Science Business Overview
Table 75. Meridian Life Science Product
Table 76. Meridian Life Science Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 77. Meridian Life Science Recent Development
Table 78. Bio-Rad Laboratories Company Details
Table 79. Bio-Rad Laboratories Business Overview
Table 80. Bio-Rad Laboratories Product
Table 81. Bio-Rad Laboratories Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 82. Bio-Rad Laboratories Recent Development
Table 83. Abbott (ALERE) Company Details
Table 84. Abbott (ALERE) Business Overview
Table 85. Abbott (ALERE) Product
Table 86. Abbott (ALERE) Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 87. Abbott (ALERE) Recent Development
Table 88. bioMerieux SA Company Details
Table 89. bioMerieux SA Business Overview
Table 90. bioMerieux SA Product
Table 91. bioMerieux SA Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 92. bioMerieux SA Recent Development
Table 93. Trinity Biotech Business Overview
Table 94. Trinity Biotech Product
Table 95. Trinity Biotech Company Details
Table 96. Trinity Biotech Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 97. Trinity Biotech Recent Development
Table 98. DiaSorin Molecular Company Details
Table 99. DiaSorin Molecular Business Overview
Table 100. DiaSorin Molecular Product
Table 101. DiaSorin Molecular Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 102. DiaSorin Molecular Recent Development
Table 103. Etta Healthcare (Ovagene Oncology) Company Details
Table 104. Etta Healthcare (Ovagene Oncology) Business Overview
Table 105. Etta Healthcare (Ovagene Oncology) Product
Table 106. Etta Healthcare (Ovagene Oncology) Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 107. Etta Healthcare (Ovagene Oncology) Recent Development
Table 108. ExcitePCR (PositiveID Corporation) Company Details
Table 109. ExcitePCR (PositiveID Corporation) Business Overview
Table 110. ExcitePCR (PositiveID Corporation) Product
Table 111. ExcitePCR (PositiveID Corporation) Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 112. ExcitePCR (PositiveID Corporation) Recent Development
Table 113. Flow Alliance Company Details
Table 114. Flow Alliance Business Overview
Table 115. Flow Alliance Product
Table 116. Flow Alliance Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 117. Flow Alliance Recent Development
Table 118. Fluid-Screen Company Details
Table 119. Fluid-Screen Business Overview
Table 120. Fluid-Screen Product
Table 121. Fluid-Screen Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 122. Fluid-Screen Recent Development
Table 123. FluimediX Company Details
Table 124. FluimediX Business Overview
Table 125. FluimediX Product
Table 126. FluimediX Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 127. FluimediX Recent Development
Table 128. Fluxergy Company Details
Table 129. Fluxergy Business Overview
Table 130. Fluxergy Product
Table 131. Fluxergy Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 132. Fluxergy Recent Development
Table 133. Focus Diagnostics (DiaSorin Molecular) Company Details
Table 134. Focus Diagnostics (DiaSorin Molecular) Business Overview
Table 135. Focus Diagnostics (DiaSorin Molecular) Product
Table 136. Focus Diagnostics (DiaSorin Molecular) Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 137. Focus Diagnostics (DiaSorin Molecular) Recent Development
Table 138. Future Horizon Scientific Company Details
Table 139. Future Horizon Scientific Business Overview
Table 140. Future Horizon Scientific Product
Table 141. Future Horizon Scientific Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 142. Future Horizon Scientific Recent Development
Table 143. Genalyte Company Details
Table 144. Genalyte Business Overview
Table 145. Genalyte Product
Table 146. Genalyte Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 147. Genalyte Recent Development
Table 148. GeneFluidics Company Details
Table 149. GeneFluidics Business Overview
Table 150. GeneFluidics Product
Table 151. GeneFluidics Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 152. GeneFluidics Recent Development
Table 153. GenSpeed Biotech Company Details
Table 154. GenSpeed Biotech Business Overview
Table 155. GenSpeed Biotech Product
Table 156. GenSpeed Biotech Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 157. GenSpeed Biotech Recent Development
Table 158. Gulf Bio Analytical Company Details
Table 159. Gulf Bio Analytical Business Overview
Table 160. Gulf Bio Analytical Product
Table 161. Gulf Bio Analytical Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 162. Gulf Bio Analytical Recent Development
Table 163. Hahn-Schickard Company Details
Table 164. Hahn-Schickard Business Overview
Table 165. Hahn-Schickard Product
Table 166. Hahn-Schickard Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 167. Hahn-Schickard Recent Development
Table 168. Helvoet Company Details
Table 169. Helvoet Business Overview
Table 170. Helvoet Product
Table 171. Helvoet Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 172. Helvoet Recent Development
Table 173. HemoCue Company Details
Table 174. HemoCue Business Overview
Table 175. HemoCue Product
Table 176. HemoCue Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 177. HemoCue Recent Development
Table 178. Danaher Company Details
Table 179. Danaher Business Overview
Table 180. Danaher Product
Table 181. Danaher Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 182. Danaher Recent Development
Table 183. IDEX Health&Science Company Details
Table 184. IDEX Health&Science Business Overview
Table 185. IDEX Health&Science Product
Table 186. IDEX Health&Science Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 187. IDEX Health&Science Recent Development
Table 188. iLine Microsystems Company Details
Table 189. iLine Microsystems Business Overview
Table 190. iLine Microsystems Product
Table 191. iLine Microsystems Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 192. iLine Microsystems Recent Development
Table 193. Inflammatix Company Details
Table 194. Inflammatix Business Overview
Table 195. Inflammatix Product
Table 196. Inflammatix Revenue in PCR-based Enteric Disease Testing Business (2015-2020) (US$ Million)
Table 197. Inflammatix Recent Development
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global PCR-based Enteric Disease Testing Market Share by Type: 2020 VS 2026
Figure 2. Analyzers/Instruments Features
Figure 3. Kits/Panels Features
Figure 4. Global PCR-based Enteric Disease Testing Market Share by Application: 2020 VS 2026
Figure 5. Clostridium Difficile Case Studies
Figure 6. Campylobacteriosis Case Studies
Figure 7. Cholera Case Studies
Figure 8. E. coli Infection Case Studies
Figure 9. H. pylori Infection Case Studies
Figure 10. Salmonellosis Case Studies
Figure 11. Shigellosis Case Studies
Figure 12. Rotavirus Infection Case Studies
Figure 13. Norovirus Infection Case Studies
Figure 14. Parasitic Enteric Disease Case Studies
Figure 15. PCR-based Enteric Disease Testing Report Years Considered
Figure 16. Global PCR-based Enteric Disease Testing Market Size (US$ Million), YoY Growth 2015-2026
Figure 17. Global PCR-based Enteric Disease Testing Market Share by Regions: 2020 VS 2026
Figure 18. Global PCR-based Enteric Disease Testing Market Share by Regions (2021-2026)
Figure 19. Global PCR-based Enteric Disease Testing Market Share by Players in 2019
Figure 20. Global Top PCR-based Enteric Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PCR-based Enteric Disease Testing as of 2019
Figure 21. The Top 10 and 5 Players Market Share by PCR-based Enteric Disease Testing Revenue in 2019
Figure 22. North America PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. United States PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Canada PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Europe PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Germany PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. France PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. U.K. PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Italy PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Russia PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Nordic PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Rest of Europe PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Asia-Pacific PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. China PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Japan PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. South Korea PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Southeast Asia PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. India PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Australia PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Rest of Asia-Pacific PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Latin America PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Mexico PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Brazil PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Middle East & Africa PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Turkey PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. Saudi Arabia PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 47. UAE PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 48. Rest of Middle East & Africa PCR-based Enteric Disease Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 49. Thermo Fisher Scientific Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 50. Vela Diagnostics Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 51. CorisBioconcept Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 52. Meridian Life Science Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 53. Bio-Rad Laboratories Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 54. Abbott (ALERE) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 55. bioMerieux SA Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 56. Trinity Biotech Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 57. DiaSorin Molecular Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 58. Etta Healthcare (Ovagene Oncology) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 59. ExcitePCR (PositiveID Corporation) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 60. Flow Alliance Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 61. Fluid-Screen Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 62. FluimediX Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 63. Fluxergy Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 64. Focus Diagnostics (DiaSorin Molecular) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 65. Future Horizon Scientific Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 66. Genalyte Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 67. GeneFluidics Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 68. GenSpeed Biotech Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 69. Gulf Bio Analytical Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 70. Hahn-Schickard Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 71. Helvoet Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 72. HemoCue Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 73. Danaher Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 74. IDEX Health&Science Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 75. iLine Microsystems Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 76. Inflammatix Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2015-2020)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed